GRIN2A and ischemic stroke: Elevated plasma levels of the autoantibodies to NR2A/2B NMDA receptor subunits in plasma were reported in patients with TIAs and ischemic stroke, and the levels of NR2A/2B autoantibodies measured within 72 h differentiated ischemic stroke from intracerebral hemorrhage (ICH) [16].